188 related articles for article (PubMed ID: 14501791)
1. Differences in HIV-1 pol sequences from female genital tract and blood during antiretroviral therapy.
De Pasquale MP; Leigh Brown AJ; Uvin SC; Allega-Ingersoll J; Caliendo AM; Sutton L; Donahue S; D'Aquila RT
J Acquir Immune Defic Syndr; 2003 Sep; 34(1):37-44. PubMed ID: 14501791
[TBL] [Abstract][Full Text] [Related]
2. Differential virus evolution in blood and genital tract of HIV-infected females: evidence for the involvement of drug and non-drug resistance-associated mutations.
Tirado G; Jove G; Kumar R; Noel RJ; Reyes E; Sepulveda G; Yamamura Y; Kumar A
Virology; 2004 Jul; 324(2):577-86. PubMed ID: 15207642
[TBL] [Abstract][Full Text] [Related]
3. Effect of highly active antiretroviral therapy on cervicovaginal HIV-1 RNA.
Cu-Uvin S; Caliendo AM; Reinert S; Chang A; Juliano-Remollino C; Flanigan TP; Mayer KH; Carpenter CC
AIDS; 2000 Mar; 14(4):415-21. PubMed ID: 10770544
[TBL] [Abstract][Full Text] [Related]
4. Detection of multiple drug-resistance-associated pol mutations in cervicovaginal secretions from women largely treated with antiretroviral agents.
Di Stefano M; Fiore JR; Monno L; Lepera A; Pastore G; Angarano G
AIDS; 1999 May; 13(8):992-4. PubMed ID: 10371183
[No Abstract] [Full Text] [Related]
5. Lack of effect of compartmentalized drug resistance mutations on HIV-1 pol divergence in antiretroviral-experienced women.
Kelley CF; Sullivan ST; Lennox JL; Evans-Strickfaden T; Hart CE
AIDS; 2010 Jun; 24(9):1361-6. PubMed ID: 20389234
[TBL] [Abstract][Full Text] [Related]
6. Correlates of HIV-1 shedding in cervicovaginal secretions and effects of antiretroviral therapies.
Fiore JR; Suligoi B; Saracino A; Di Stefano M; Bugarini R; Lepera A; Favia A; Monno L; Angarano G; Pastore G
AIDS; 2003 Oct; 17(15):2169-76. PubMed ID: 14523273
[TBL] [Abstract][Full Text] [Related]
7. Genital Shedding of Human Immunodeficiency Virus Type-1 (HIV) When Antiretroviral Therapy Suppresses HIV Replication in the Plasma.
Bull M; Mitchell C; Soria J; Styrchak S; Williams C; Dragavon J; Ryan KJ; Acosta E; Onchiri F; Coombs RW; La Rosa A; Ticona E; Frenkel LM
J Infect Dis; 2020 Aug; 222(5):777-786. PubMed ID: 32274499
[TBL] [Abstract][Full Text] [Related]
8. Compartmentalization of drug resistance-associated mutations in a treatment-naive HIV-infected female.
Tirado G; Jove G; Kumar R; Noel RJ; Reyes E; Sepulveda G; Yamamura Y; Kumar A
AIDS Res Hum Retroviruses; 2004 Jun; 20(6):684-6. PubMed ID: 15242547
[TBL] [Abstract][Full Text] [Related]
9. HIV type 2 protease, reverse transcriptase, and envelope viral variation in the PBMC and genital tract of ARV-naive women in Senegal.
Gottlieb GS; Hawes SE; Wong KG; Raugi DN; Agne HD; Critchlow CW; Kiviat NB; Sow PS
AIDS Res Hum Retroviruses; 2008 Jun; 24(6):857-64. PubMed ID: 18544024
[TBL] [Abstract][Full Text] [Related]
10. Selection of drug-resistant variants in the female genital tract of human immunodeficiency virus type 1-infected women receiving antiretroviral therapy.
Si-Mohamed A; Kazatchkine MD; Heard I; Goujon C; Prazuck T; Aymard G; Cessot G; Kuo YH; Bernard MC; Diquet B; Malkin JE; Gutmann L; Bélec L
J Infect Dis; 2000 Jul; 182(1):112-22. PubMed ID: 10882588
[TBL] [Abstract][Full Text] [Related]
11. Cervicovaginal human immunodeficiency virus secretion and plasma viral load in human immunodeficiency virus-seropositive women.
Uvin SC; Caliendo AM
Obstet Gynecol; 1997 Nov; 90(5):739-43. PubMed ID: 9351756
[TBL] [Abstract][Full Text] [Related]
12. Phylogenetic Analyses Comparing HIV Sequences from Plasma at Virologic Failure to Cervix Versus Blood Sequences from Antecedent Antiretroviral Therapy Suppression.
Bull ME; McKernan JL; Styrchak S; Kraft K; Hitti J; Cohn SE; Tapia K; Deng W; Holte S; Mullins JI; Coombs RW; Frenkel LM
AIDS Res Hum Retroviruses; 2019 Jun; 35(6):557-566. PubMed ID: 30892052
[TBL] [Abstract][Full Text] [Related]
13. HIV-1 drug resistance in variants from the female genital tract and plasma.
Kemal KS; Burger H; Mayers D; Anastos K; Foley B; Kitchen C; Huggins P; Schroeder T; Picchio G; Back S; Gao W; Meyer WA; Weiser B
J Infect Dis; 2007 Feb; 195(4):535-45. PubMed ID: 17230413
[TBL] [Abstract][Full Text] [Related]
14. HIV-1 drug resistance profiles in children and adults with viral load of <50 copies/ml receiving combination therapy.
Hermankova M; Ray SC; Ruff C; Powell-Davis M; Ingersoll R; D'Aquila RT; Quinn TC; Siliciano JD; Siliciano RF; Persaud D
JAMA; 2001 Jul; 286(2):196-207. PubMed ID: 11448283
[TBL] [Abstract][Full Text] [Related]
15. Genetic and phenotypic features of blood and genital viral populations of clinically asymptomatic and antiretroviral-treatment-naive clade a human immunodeficiency virus type 1-infected women.
Andreoletti L; Skrabal K; Perrin V; Chomont N; Saragosti S; Gresenguet G; Moret H; Jacques J; Longo Jde D; Matta M; Mammano F; Belec L
J Clin Microbiol; 2007 Jun; 45(6):1838-42. PubMed ID: 17460054
[TBL] [Abstract][Full Text] [Related]
16. Differential evolution of cell-associated virus in blood and genital tract of HIV-infected females undergoing HAART.
Tirado G; Jove G; Reyes E; Sepulveda G; Yamamura Y; Singh DP; Kumar A
Virology; 2005 Apr; 334(2):299-305. PubMed ID: 15780880
[TBL] [Abstract][Full Text] [Related]
17. HIV type 1 BF recombinant strains exhibit different pol gene mosaic patterns: descriptive analysis from 284 patients under treatment failure.
Quarleri JF; Rubio A; Carobene M; Turk G; Vignoles M; Harrigan RP; Montaner JS; Salomón H; Gómez-Carrillo M
AIDS Res Hum Retroviruses; 2004 Oct; 20(10):1100-7. PubMed ID: 15585101
[TBL] [Abstract][Full Text] [Related]
18. Natural residues versus antiretroviral drug-selected mutations in HIV type 1 group O reverse transcriptase and protease related to virological drug failure in vivo.
de Baar MP; Janssens W; de Ronde A; Fransen K; Colebunders R; Kestens L; van der Groen G; Goudsmit J
AIDS Res Hum Retroviruses; 2000 Sep; 16(14):1385-94. PubMed ID: 11018858
[TBL] [Abstract][Full Text] [Related]
19. Long-term suppression of plasma viremia with highly active antiretroviral therapy despite virus evolution and very limited selection of drug-resistant genotypes.
Pariente N; Pernas M; de la Rosa R; Gómez-Mariano G; Fernández G; Rubio A; López M; Benito JM; López-Galíndez C; Leal M; Domingo E; Martinez MA; Mas A
J Med Virol; 2004 Jul; 73(3):350-61. PubMed ID: 15170628
[TBL] [Abstract][Full Text] [Related]
20. HIV-1 drug resistance in newly infected individuals.
Boden D; Hurley A; Zhang L; Cao Y; Guo Y; Jones E; Tsay J; Ip J; Farthing C; Limoli K; Parkin N; Markowitz M
JAMA; 1999 Sep 22-29; 282(12):1135-41. PubMed ID: 10501116
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
